# V260 Registration Study (V260-013)(COMPLETED)

> **NCT00166517** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 178 (actual)

## Conditions studied

- Rotavirus

## Interventions

- **BIOLOGICAL:** Rotavirus Vaccine, Live, Oral, Pentavalent
- **BIOLOGICAL:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00166517
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2015-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166517, "V260 Registration Study (V260-013)(COMPLETED)". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00166517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*